CRL-40,941

From Self-sufficiency
Revision as of 20:28, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): nervous-system-drug-stub)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
CRL-40,941
File:Bisfluoroadrafinil.png
Systematic (IUPAC) name
2-[bis(4-fluorophenyl)methyl]sulfinylethanehydroxamic acid
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Unscheduled (US)
Identifiers
ATC code none
Chemical data
Formula C15H13F2NO3S
Molar mass 325.33 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

CRL-40,941 is a mild central nervous system stimulant drug closely related to adrafinil and modafinil. It is the bis(p-fluoro) ring-substituted derivative of adrafinil, and has similar effects in animal tests and human trials, although the fluorine substitution increases the potency to around twice that of adrafinil itself, and CRL-40941 was also found to produce anti-aggressive effects in animals which adrafinil does not produce.[1]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Louis Lafon. Halogenobenzhydrylsulfinylacetohydroxamic acids. U.S. Patent 4,489,095, issued to Laboratoire L. Lafon on Dec 18, 1984